COPD

Glaxo Tries To Turn A Triple Play
Seeking Alpha
Wed, 02/11/15 - 09:11 am
GSK
COPD
Chiesi
AstraZeneca
Novartis
Biogen Idec
GSK and Theravance Announce Start of Phase III Lung Function Study With 'Closed' Triple Combination Treatment FF/UMEC/VI for COPD
Yahoo
Mon, 02/9/15 - 08:18 am
GSK
Theravance
fluticasone furoate/umeclidinium/vilanterol
COPD
GSK Expands Portfolio of Asthma/COPD Medicines in U.S.
Drug Discovery and Development
Mon, 01/26/15 - 06:53 pm
GSK
asthma
COPD
Incruse Ellipta
Arnuity Ellipta
Novartis Seeks U.S. Approval for Two COPD Drugs
Bloomberg
Thu, 01/8/15 - 08:00 am
Novartis
COPD
QVA149
NVA237
Britain's Vectura collaborates with Janssen in asthma, COPD
Yahoo/Reuters
Tue, 01/6/15 - 08:44 am
Janssen
JNJ
Vectura
asthma
COPD
Anoro Ellipta beats Spiriva HandiHaler in COPD trial
Seeking Alpha
Fri, 10/17/14 - 10:12 am
Anoro Ellipta
Spiriva HandiHaler
COPD
GSK
Boehringer Ingelheim
Boehringer Ingelheim Announces FDA Approval of Spiriva® Respimat® for the Maintenance Treatment of COPD
Marketwatch
Thu, 09/25/14 - 08:59 am
Boehringer Ingelheim
FDA
Spiriva
COPD
Boehringer's next-gen COPD treatment hits the mark in Phase III
Fierce Biotech
Tue, 09/9/14 - 10:26 am
Boehringer Ingelheim
COPD
Striverdi
Spiriva
AstraZeneca's self-styled 'blockbuster' benralizumab tanks in severe COPD study
Fierce Biotech
Mon, 09/8/14 - 07:55 am
AstraZeneca
benralizumab
COPD
GSK gets a lift as Express Scripts reinstates lung drug Advair
Yahoo/Reuters
Mon, 08/4/14 - 11:41 am
GSK
Express Scripts
Advair
COPD
asthma
FDA approves Boehringer's once-a-day inhaler drug
Yahoo/AP
Thu, 07/31/14 - 03:58 pm
FDA
Boehringer Ingelheim
Striverdi Respimat
COPD
GSK, Theravance announce positive data from two phase III studies
The Fly on the Wall
Wed, 06/11/14 - 09:06 am
GSK
Theravance
COPD
Relvar Ellipta
Novartis, Boehringer vie for COPD market share with combo meds
Fierce Biotech
Thu, 05/22/14 - 11:57 am
COPD
Novartis
Boehringer Ingelheim
LAMA/LABA
GlaxoSmithKline reports positive data from Incruse Ellipta study
The Fly on the Wall
Tue, 05/20/14 - 09:14 am
GSK
COPD
Incruse Ellipta
GSK receives approval for Incruse™ Ellipta® (umeclidinium) in the US for the treatment of COPD
Marketwatch
Thu, 05/1/14 - 10:03 am
GSK
FDA
Incruse Ellipta
COPD
GSK, Theravance announce Anoro Ellipta available in U.S. for treatment of COPD
The Fly on the Wall
Mon, 04/28/14 - 08:50 am
COPD
Anoro Ellipta
GSK
Theravance
Novartis INSTEAD study for Onbrez Breezhaler meets primary objective
Yahoo/Fly on the Wall
Fri, 04/25/14 - 08:14 am
Novartis
Onbrez Breezhaler
COPD
Almirall Drops on U.S. Regulator’s Scrutiny of Lung Drug
Bloomberg
Wed, 04/9/14 - 11:28 am
Almirall
FDA
Forest Labs
COPD
formoterol
aclidinium
GlaxoSmithKline's COPD drug Anoro receives European green light
Reuters
Thu, 02/20/14 - 08:44 am
GSK
COPD
Europe
Anoro
Theravance
Glaxo’s Advair Loses U.S. Market Share to Astra, Merck
Bloomberg
Tue, 02/4/14 - 06:54 pm
GSK
Advair
AstraZeneca
Merck
COPD

Pages